<DOC>
	<DOC>NCT00747448</DOC>
	<brief_summary>The purpose of this study is to create a patient registry to collect and analyze post-510K approval information on subjects treated endoscopically with the CryoSpray Ablation™ System.</brief_summary>
	<brief_title>CryoSpray Ablation (TM) GI Patient Registry</brief_title>
	<detailed_description>The proposed registry is a prospective, multi-center study of patients that are being currently undergoing CryoSpray Ablation™. It will also be used to catalogue retrospective data from records of patients already treated with the device. A maximum of 40 investigational sites will participate in this study.</detailed_description>
	<mesh_term>Esophageal Neoplasms</mesh_term>
	<mesh_term>Barrett Esophagus</mesh_term>
	<criteria>The study population consists of patients who are being treated, or were treated, with the CryoSpray Ablation™ System for malignant or premalignant conditions of the esophagus, including: Barrett's esophagus with or without dysplasia Squamous dysplasia of the esophagus Esophageal cancer, any stage Subjects with esophageal lesions whose pathology was not one of the above. Subjects with one of the above conditions who were not treated with the CryoSpray Ablation™ System.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2016</verification_date>
	<keyword>Barrett's Esophagus</keyword>
	<keyword>High Grade Dysplasia</keyword>
	<keyword>Low Grade Dysplasia</keyword>
	<keyword>Squamous Dysplasia</keyword>
	<keyword>Esophageal Cancer</keyword>
	<keyword>CryoSpray Ablation</keyword>
	<keyword>Cryotherapy</keyword>
	<keyword>Cryospray</keyword>
</DOC>